3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino] -3-methylbutyramide Analogues as Selective DPP-IV Inhibitors for the Treatment of Type-II Diabetes.

✍ Scribed by Weir-Torn Jiaang; et al. et al.

• Publisher: John Wiley and Sons
• Year: 2007
• Weight: 24 KB
• Volume: 38
• Category: Article
• ISSN: 0931-7597
• DOI: 10.1002/chin.200729098